How to Get Cosentyx (secukinumab) Covered by Blue Cross Blue Shield of Illinois: Complete Coding, PA, and Appeals Guide
Answer Box: Getting Cosentyx Approved in Illinois
Cosentyx (secukinumab) requires prior authorization through Blue Cross Blue Shield of Illinois for 2024-2025, using HCPCS code J3247 for IV formulation or J3590 for subcutaneous. Submit PA requests with proper ICD-10 codes (L40.0 for plaque psoriasis, L40.50-59 for psoriatic arthritis), tuberculosis